Litcius/Paper detail

Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma

Jingjing Li, Jiu-hong Wang, Ya Dingv, Dandan Li, Xizhi Wen, Jingjing Zhao, Hang Jiang, Xing Liu, Fuxue Huang, Xiaoshi Zhang

2021Journal of Cancer Research and Clinical Oncology25 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineNeutropeniaGastroenterologyAdverse effectRefractory (planetary science)Retrospective cohort studySurgeryChemotherapyAstrobiologyPhysicsCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementMelanoma and MAPK Pathways
Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma | Litcius